Skip to main content
Premium Trial:

Request an Annual Quote

Elsevier Buys Ariadne Genomics

NEW YORK (GenomeWeb News) – Scientific publishing firm Elsevier today announced it is buying the assets of genomics analysis firm Ariadne Genomics for an undisclosed amount.

Headquartered in Rockville, Md., Ariadne's flagship product is Pathway Studio for the analyses of molecular pathways and disease progression. The software suite comprises an integrated data mining and visualization product "that organizes relevant facts and relationships from large document collections of genes, proteins, cell processes, and diseases," Elsevier said in a statement.

Pathway Studio enables visualization of biological relationships spanning biomedical literature and helps researchers interpret experimental results using domain-specific ontologies, taxonomies, and dictionaries.

Ariadne will be integrated with Elsevier's Corporate Markets division.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.